TARDBP and neurodegenerative disease: However, under the pathological conditions of various neurodegenerative diseases, we have identified that the abnormal expression of proteins such as Tau, amyloid-β, α-synuclein, huntingtin, and TDP-43 is a primary driver of neurodegenerative disease onset [94].